CardioKol

"Using Voice to Save Lives", enabling mass prevention of strokes and chronic complications over years in mass populations using voice-based markers for passive telemonitoring & screening, Cardiokol develops revolutionary affordable, scalable, long-term and age-friendly monitoring solutions. Our technology is applicable for mass at-risk populations including older adults (65+), by utilizing proprietary technology that is implemented in speech platforms such as landlines, smartphones, smart speakers and voice assistants. Cardiokol long-term strategic offering is a novel platform and a suite of solutions which allow for the first time wide scale prevention of multiple conditions, starting with Afib including prevention of acute and chronic dire complications (stroke, cardiac, kidney failure and more), at a later stage Arrhythmias, Heart diseases and Acute Chronic diseases.

CardioKol

CardioKol

Company

2023

Date

Class 5

Category
Our Champions

Leading Medical Experts

Meet the growing team of clinical Champions who engage with our startups

No items found.